Blog

Pioneering cancer gene therapy by Novartis backed by US panel – CNBC


CNBC

Pioneering cancer gene therapy by Novartis backed by US panel
CNBC
Novartis AG's pioneering cancer drug won the backing of a federal advisory panel on Wednesday, paving the way for the first gene therapy to be approved in the United States. An advisory panel to the Food and Drug Administration voted 10-0 that the drug
FDA panel backs Novartis' pioneering new cancer gene therapyReuters


Novel Leukemia Treatment Could Be 1st US Gene TherapyU.S. News & World Report
CAR-T gene therapy for leukemia clears FDA hurdleCBS News
Fox News –TIME –Sun Sentinel
all 74 news articles »

2017-07-12 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.